ENDRA Life Sciences (NDRA) Receivables (2017 - 2018)
ENDRA Life Sciences (NDRA) posted quarterly Receivables of $12275.0 for Q3 2018, up 4.29% quarter-over-quarter from $11770.0 in Q2 2018.
ENDRA Life Sciences (NDRA) Receivables (2017 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Receivables for 2 consecutive years, with $12275.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Receivables changed N/A year-over-year to $12275.0; the TTM figure through Sep 2018 stood at $12275.0 (changed N/A YoY), while the FY2017 annual figure was $6850.0, changed N/A from the prior year.
- Receivables rose to $12275.0 in Q3 2018 per NDRA's latest filing, from $11770.0 in the prior quarter.
- Across five years, Receivables topped out at $12275.0 in Q3 2018 and bottomed at $6850.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 11.14 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 3.97 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 421.97 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.50 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 5.16 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 709.36 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 791.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 731.48 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 2.50 Bn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 12,275.00 |
| Jun 30, 2018 | 11,770.00 |
| Mar 31, 2018 | 11,770.00 |
| Dec 31, 2017 | 6,850.00 |